Asset purchase https://www.bioworld.com/rss en-us Alphatec nabs Fusion Robotics’ REMI system for $55M http://www.bioworld.com/articles/696258 Thu, 20 Apr 2023 13:00:00 -0400 https://www.bioworld.com/articles/696258-alphatec-nabs-fusion-robotics-remi-system-for-55m Fusion-Quick-Compact.jpg Alphatec buys REMI robotic surgery system for $55 million. Enovis brings AR navigation to knee and hip procedures via Insight Medical Systems acquisition http://www.bioworld.com/articles/520542 Thu, 07 Jul 2022 13:00:00 -0400 https://www.bioworld.com/articles/520542-enovis-brings-ar-navigation-to-knee-and-hip-procedures-via-insight-medical-systems-acquisition Enovis Healiva to resurrect wound care cell therapies after Smith & Nephew asset acquisition BioWorld. The deal means that the Lugano-based company – which was formed in 2020 – could be booking revenues as early as 2023.]]> http://www.bioworld.com/articles/519333 Wed, 01 Jun 2022 13:00:00 -0400 https://www.bioworld.com/articles/519333-healiva-to-resurrect-wound-care-cell-therapies-after-smith-and-nephew-asset-acquisition Acquisition target Xbiome acquires drug from Assembly Biosciences to treat ulcerative colitis http://www.bioworld.com/articles/518441 Tue, 03 May 2022 13:00:00 -0400 https://www.bioworld.com/articles/518441-xbiome-acquires-drug-from-assembly-biosciences-to-treat-ulcerative-colitis Outline of intestine and person holding stomach in pain Labcorp seeks to dominate rheumatoid arthritis testing with Vectra purchase from Myriad Genetics http://www.bioworld.com/articles/506671 Mon, 03 May 2021 13:00:00 -0400 https://www.bioworld.com/articles/506671-labcorp-seeks-to-dominate-rheumatoid-arthritis-testing-with-vectra-purchase-from-myriad-genetics Arthritis pain illustration Agios sells oncology business to Servier in $2B+ deal http://www.bioworld.com/articles/501622 Mon, 21 Dec 2020 13:00:00 -0500 https://www.bioworld.com/articles/501622-agios-sells-oncology-business-to-servier-in-2b-deal Aussie immuno-oncology firm Imugene bolsters pipeline with oncolytic virus acquisition http://www.bioworld.com/articles/331711 Wed, 17 Jul 2019 00:00:00 -0400 https://www.bioworld.com/articles/331711-aussie-immuno-oncology-firm-imugene-bolsters-pipeline-with-oncolytic-virus-acquisition Jazz deal seeks to move Redx out of red, into black http://www.bioworld.com/articles/355707 Thu, 11 Jul 2019 00:00:00 -0400 https://www.bioworld.com/articles/355707-jazz-deal-seeks-to-move-redx-out-of-red-into-black